Table 2 Descriptive data of Dataset 2 presented in terms of quantity (n), percentage (%), mean value and SD, including p-values from the comparisons between patients with and without sLWF.
Parameter | All patients | Patients with sLWF | Patients without sLWF | p-value |
|---|---|---|---|---|
Included patients (n, %) | 202 (100.0) | 42 (20.8) | 160 (79.2) | – |
Patients with AO/OTA 31-A1 fractures (n, %) | 93 (46.0) | 3 (3.2) | 90 (96.8) | – |
Patients with AO/OTA 31-A2 fractures (n, %) | 109 (54.0) | 39 (35.8) | 70 (64.2) | – |
rLWT among all patients (mean value ± SD, %) | 57.8 ± 16.1 | 42.7 ± 10.5 | 61.8 ± 15.0 | < 0.001 [95% CI 14.4–24.0] |
rLWT among patients with AO/OTA 31-A1 fractures (mean value ± SD, %) | 66.1 ± 14.6 | 40.7 ± 9.9 | 66.9 ± 14.0 | 0.002 [95% CI 10.0–42.5] |
rLWT among patients with AO/OTA 31-A2 fractures (mean value ± SD, %) | 50.8 ± 14.0 | 42.9 ± 10.7 | 55.3 ± 13.7 | < 0.001 [95% CI 7.4–17.4] |